Latest On Orion Oyj (ORINY):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-03-21 06:03 EST | Dividend | A dividend of $0.44 has been announced on Feb 27, 2024. It will be paid Nov 30, -0001 with an ex-dividend date of Mar 21, 2024. | Neutral |  |
| 2023-03-23 11:59 EST | News | Bayer, Orion begin phase 3 trial of Nubeqa to expand prostate cancer indication | N/A | |
| 2023-03-23 06:01 EST | Dividend | A dividend of $0.85 has been announced on Feb 10, 2023. It will be paid Apr 17, 2023 with an ex-dividend date of Mar 23, 2023. | Neutral | |
| 2023-03-01 20:21 EST | News | Orion wins EU approval for darolutamide for additional indication in prostate cancer | N/A | |
| 2023-02-27 09:18 EST | News | Orion wins approval for darolutamide in Japan for metastatic prostate cancer | N/A | |
| 2022-07-16 00:06 EST | News | Orion Oyj (ORINF) CEO Timo Lappalainen on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-07-15 06:55 EST | News | Orion Oyj 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-06-15 19:25 EST | News | Orion acquires Inovet’s animal health business for ~EUR 130M debt free | N/A | |
| 2022-05-01 03:34 EST | News | Orion Oyj (ORINF) CEO Timo Lappalainen on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-03-24 06:02 EST | Dividend | A dividend of $0.85 has been announced on Feb 11, 2022. It will be paid Apr 18, 2022 with an ex-dividend date of Mar 24, 2022. | Neutral | |
| 2021-03-26 06:04 EST | Dividend | A dividend of $0.91 has been announced on Nov 30, -0001. It will be paid Apr 22, 2021 with an ex-dividend date of Mar 26, 2021. | Neutral | |
| 2021-02-10 13:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 23:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 02:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-02 19:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 15:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 17:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 19:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 07:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 03:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-07 06:16 EST | Dividend | A dividend of $0.81 has been announced on Apr 22, 2020. It will be paid Jun 1, 2020 with an ex-dividend date of May 7, 2020. | Neutral | |
| 2020-05-06 07:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 18:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 06:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-09 22:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 23:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-26 06:07 EST | Dividend | A dividend of $0.83 has been announced on Mar 2, 2020. It will be paid Apr 20, 2020 with an ex-dividend date of Mar 26, 2020. | Neutral | |
| 2020-03-25 22:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 06:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 00:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-22 01:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-21 01:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-18 01:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-13 01:50 EST | Financials | Company financials have been released. | Neutral | |
About Orion Oyj (ORINY):
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company has a collaboration with Nanoform to apply Nanoform's CESS technology to new chemical entities. It serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) line of inhalers for asthma and COPD to Propeller's digital medicine platform. Orion Oyj is headquartered in Espoo, Finland.
General
- Name Orion Oyj
- Symbol ORINY
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-General
- Full Time Employees 3,311
- Fiscal Year EndDecember
- Web URLhttp://www.orion.fi
View More
Valuation
- Trailing PE 21.89
- Forward PE 28.9
- Price/Sales (Trailing 12 Mt.) 4.49
- Price/Book (Most Recent Quarter) 6.62
- Enterprise Value Revenue 5.17
- Enterprise Value EBITDA 16.6
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 20%
- Return on Assets 16%
- Return on Equity 29%
- Earnings Per Share $1.37
- Revenue Per Share $0
- Gross Profit 651.1 million
- Quarterly Earnings Growth -7%
View More
Highlights
- Market Capitalization 5.89 billion
- Book Value Per Share $3.05
View More
Share Statistics
- Shares Outstanding 280.93 million
- Shares Float 253.71 million
- % Held by Insiders <1%
View More
Technicals
- Beta 0.5
- 52 Week High $27
- 52 Week Low $17.04
- 50 Day Moving Average 21.28
- 200 Day Moving Average 22.77
View More
Dividends
- Forward Annual Dividend Rate $0.91
- Forward Annual Dividend Yield 4.43%
- Payout Ratio 187%
- Dividend Date 2021-04-22
- ExDividend Date 2021-03-26
- Dividend Per Share $0.91
- Dividend Yield 0%
View More
Orion Oyj (ORINY) Dividend Calendar:
ORINY's last dividend payment was made to shareholders on April 22, 2021.
Orion Oyj pays out 187% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Orion Oyj (ORINY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | $N/A | $0.11 | ||
| 2020-09-30 | 2020-12-31 | $250.3 million | $0.22 | ||
| 2020-06-30 | 2020-09-30 | $292.5 million | $0.43 | ||
| 2020-03-31 | 2020-06-30 | $279.9 million | $0.61 | ||
| 2019-12-31 | 2020-03-31 | $274.5 million | $0.53 | ||
| 2019-09-30 | 2019-12-31 | $283.7 million | $0.36 | ||
| 2019-06-30 | 2019-09-30 | $251.7 million | $0.56 | ||
| 2019-03-31 | 2019-06-30 | $241 million | $0.33 | ||
| 2018-12-31 | 2019-03-31 | $262.4 million | $0.34 | ||
| 2018-09-30 | 2018-09-30 | $221.8 million | $0.14 | ||
| 2018-06-30 | 2018-09-30 | $246.1 million | $0.28 | ||
| 2018-03-31 | 2018-06-30 | $247.2 million | $0.46 | ||
| 2017-12-31 | 2018-03-31 | $280.3 million | $0.47 | ||
| 2017-09-30 | 2017-12-31 | $252.7 million | $0.46 | ||
| 2017-06-30 | 2017-09-30 | $272.4 million | $0.35 | ||
| 2017-03-31 | 2017-06-30 | $279.2 million | $0.45 | ||
| 2016-12-31 | 2017-03-31 | $279.9 million | $0.51 | ||
| 2016-09-30 | 2016-12-31 | $0.36 | |||
| 2016-06-30 | 2016-09-30 | $0.58 | |||
| 2016-03-31 | 2016-06-30 | $0.52 | |||
| 2015-12-31 | 2016-03-31 | $0.51 | |||
| 2015-09-30 | 2015-12-31 | $0.30 | |||
| 2015-06-30 | 2015-09-30 | $0.36 | |||
| 2015-03-31 | 2015-06-30 | $0.46 | |||
| 2014-12-31 | 2015-03-31 | $0.50 | |||
| 2014-09-30 | 2014-12-31 | $0.35 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | $0.44 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.66 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.51 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.54 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.47 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.42 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.50 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.39 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.51 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.44 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.56 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.42 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.46 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.49 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.69 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.35 | $0.00 |
Orion Oyj (ORINY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | 25.6 million | 32.3 million | 26.8 million | 32.8 million |
| Income Before Tax | N/A | 64.6 million | 96.5 million | 83.4 million | 54.7 million |
| Selling General Administrative | N/A | 56.1 million | 62.4 million | 66.3 million | 74.2 million |
| Gross Profit | N/A | 145.2 million | 191 million | 175.1 million | 161.5 million |
| Ebit | N/A | 65.2 million | 96.5 million | 84.4 million | 54.9 million |
| Operating Income | N/A | 65.1 million | 96.4 million | 84.4 million | 54.9 million |
| Income Tax Expense | 8.3 million | 13.2 million | 20.9 million | 16 million | 9.5 million |
| Total Revenue | N/A | 250.3 million | 292.5 million | 279.9 million | 274.5 million |
| Cost of Revenue | N/A | 105.1 million | 101.5 million | 104.8 million | 113 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -200000 |
| Net Income From Continuing Operations | N/A | 51.4 million | 75.6 million | 67.4 million | 45.2 million |
| Net Income Applicable to Common Shares | 25.5 million | 51.4 million | 75.6 million | 67.4 million | 45.2 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -9.4 million | -9.3 million | -11.8 million | N/A | N/A |
| Change to Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | -9.4 million | N/A | -11.8 million | -8 million | -8.3 million |
| Net Borrowings | -50.9 million | N/A | 149.3 million | -1.3 million | -31 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | -1.4 million | -31.8 million |
| Change to Operating Activities | 33.4 million | N/A | -28.2 million | 4.3 million | 15.9 million |
| Change in Cash | 35.8 million | -132.6 million | 196.9 million | 55 million | 66.8 million |
| Total Cash from Operating Activities | 96.1 million | 87.8 million | 59.6 million | 64.8 million | 107.6 million |
| Depreciation | N/A | N/A | N/A | 14.6 million | 13.9 million |
| Other Cash Flow from Investing Activities | -100000 | N/A | 100000 | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | -100000 | N/A | N/A | -100000 | -100000 |
| Change to Net Income | -3.1 million | N/A | 6.2 million | 700000 | 6.2 million |
| Capital Expenditures | 9.5 million | 9.7 million | 12.1 million | 7.3 million | 8.4 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 339.4 million | 396.5 million | 401.1 million | 256.3 million |
| Total Stockholder Equity | N/A | 761 million | 709.8 million | 842.6 million | 779.4 million |
| Other Current Liabilities | 124.3 million | 98.9 million | 100.5 million | 109.8 million | 105.2 million |
| Total Assets | N/A | 1.1 billion | 1.11 billion | 1.24 billion | 1.04 billion |
| Common Stock | 92.2 million | 92.2 million | N/A | 92.2 million | 92.2 million |
| Other Current Assets | -100000 | -100000 | N/A | N/A | N/A |
| Retained Earnings | 635.7 million | 665.8 million | 614.6 million | 747.4 million | 685.2 million |
| Other Liabilities | 64.7 million | 60.4 million | N/A | 60.8 million | 62.1 million |
| Other Assets | 9 million | 58.6 million | N/A | 58.3 million | 63.3 million |
| Cash | N/A | 223.6 million | 184.7 million | 316.6 million | 114 million |
| Total Current Liabilities | 214.1 million | 173.6 million | 228.9 million | 234.5 million | 187.5 million |
| Other Stockholder Equity | 3.4 million | 21.5 million | N/A | 21 million | 26.5 million |
| Property, Plant & Equipment | 319.6 million | 317.3 million | N/A | 319.9 million | 320.9 million |
| Total Current Assets | 743.7 million | 683.3 million | 682.4 million | 817.7 million | 600.1 million |
| Long Term Investments | N/A | N/A | N/A | N/A | 300000 |
| Net Tangible Assets | 688.3 million | 720 million | 795 million | 795 million | 728.3 million |
| Short Term Investments | N/A | 24.9 million | 27.7 million | 27.4 million | 35 million |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | 258.1 million | 254.6 million | 251.1 million | 232.2 million | 230.3 million |
| Accounts Payable | 86.7 million | 67.6 million | 66.8 million | 70.6 million | 79 million |
Orion Oyj (ORINY) Chart:
Orion Oyj (ORINY) News:
Below you will find a list of latest news for Orion Oyj (ORINY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Orion Oyj (ORINY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Orion Oyj (ORINY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|